|
Volumn 52, Issue 2, 2002, Pages 73-80
|
Comparing β-blockers and their relevance in the pharmacotherapy of cardiovascular diseases;β-blocker und ihre bedeutung für die pharmakotherapie kardiovaskulärer erkrankungen im vergleich
|
Author keywords
Heart failure; Hypertension; Mortality studies; Myocardial infarction; Blockers
|
Indexed keywords
ATENOLOL;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
BETAXOLOL;
BISOPROLOL;
BUCINDOLOL;
CAPTOPRIL;
CARVEDILOL;
CELIPROLOL;
DIGITALIS GLYCOSIDE;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
ESMOLOL;
METOPROLOL;
NADOLOL;
OXPRENOLOL;
PENBUTOLOL;
PINDOLOL;
PLACEBO;
PROPRANOLOL;
SOTALOL;
VASODILATOR AGENT;
ADRENERGIC SYSTEM;
ATRIOVENTRICULAR CONDUCTION;
CARDIOVASCULAR DISEASE;
CLINICAL TRIAL;
DRUG EFFICACY;
DRUG ELIMINATION;
DRUG INDICATION;
DRUG MECHANISM;
DRUG METABOLISM;
DRUG SELECTIVITY;
HEART ATRIUM FIBRILLATION;
HEART FAILURE;
HEART INFARCTION;
HUMAN;
HYPERTENSION;
INTRINSIC SYMPATHOMIMETIC ACTIVITY;
LONGEVITY;
MORTALITY;
OUTCOMES RESEARCH;
REVIEW;
SINUS RHYTHM;
TREATMENT FAILURE;
|
EID: 0036167395
PISSN: 00044172
EISSN: None
Source Type: Journal
DOI: 10.1055/s-0031-1299860 Document Type: Review |
Times cited : (4)
|
References (33)
|